2352 related articles for article (PubMed ID: 16806720)
1. Limited brain diffusion of the glucocorticoid receptor agonist RU28362 following i.c.v. administration: implications for i.c.v. drug delivery and glucocorticoid negative feedback in the hypothalamic-pituitary-adrenal axis.
Francis AB; Pace TW; Ginsberg AB; Rubin BA; Spencer RL
Neuroscience; 2006 Sep; 141(3):1503-15. PubMed ID: 16806720
[TBL] [Abstract][Full Text] [Related]
2. Specific and time-dependent effects of glucocorticoid receptor agonist RU28362 on stress-induced pro-opiomelanocortin hnRNA, c-fos mRNA and zif268 mRNA in the pituitary.
Ginsberg AB; Frank MG; Francis AB; Rubin BA; O'Connor KA; Spencer RL
J Neuroendocrinol; 2006 Feb; 18(2):129-38. PubMed ID: 16420282
[TBL] [Abstract][Full Text] [Related]
3. Acute glucocorticoid pretreatment suppresses stress-induced hypothalamic-pituitary-adrenal axis hormone secretion and expression of corticotropin-releasing hormone hnRNA but does not affect c-fos mRNA or fos protein expression in the paraventricular nucleus of the hypothalamus.
Ginsberg AB; Campeau S; Day HE; Spencer RL
J Neuroendocrinol; 2003 Nov; 15(11):1075-83. PubMed ID: 14622438
[TBL] [Abstract][Full Text] [Related]
4. A single dose of metyrapone caused long-term dysregulation of the hypothalamic-pituitary-adrenal axis in the rat.
Rotllant D; Armario A
Neuroscience; 2005; 130(2):427-34. PubMed ID: 15664699
[TBL] [Abstract][Full Text] [Related]
5. The nociceptin/orphanin FQ antagonist UFP-101 differentially modulates the glucocorticoid response to restraint stress in rats during the peak and nadir phases of the hypothalamo-pituitary-adrenal axis circadian rhythm.
Leggett JD; Jessop DS; Fulford AJ
Neuroscience; 2007 Jul; 147(3):757-64. PubMed ID: 17574767
[TBL] [Abstract][Full Text] [Related]
6. Effect of the glucocorticoid receptor antagonist Org 34850 on basal and stress-induced corticosterone secretion.
Spiga F; Harrison LR; Wood SA; Atkinson HC; MacSweeney CP; Thomson F; Craighead M; Grassie M; Lightman SL
J Neuroendocrinol; 2007 Nov; 19(11):891-900. PubMed ID: 17927667
[TBL] [Abstract][Full Text] [Related]
7. Continuous i.c.v. infusion of brain-derived neurotrophic factor modifies hypothalamic-pituitary-adrenal axis activity, locomotor activity and body temperature rhythms in adult male rats.
Naert G; Ixart G; Tapia-Arancibia L; Givalois L
Neuroscience; 2006 May; 139(2):779-89. PubMed ID: 16457953
[TBL] [Abstract][Full Text] [Related]
8. Habituation to repeated restraint stress is associated with lack of stress-induced c-fos expression in primary sensory processing areas of the rat brain.
Girotti M; Pace TW; Gaylord RI; Rubin BA; Herman JP; Spencer RL
Neuroscience; 2006; 138(4):1067-81. PubMed ID: 16431027
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
Kumari M; Cover PO; Poyser RH; Buckingham JC
Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
[TBL] [Abstract][Full Text] [Related]
10. Long-term adaptations in glucocorticoid receptor and mineralocorticoid receptor mRNA and negative feedback on the hypothalamo-pituitary-adrenal axis following neonatal maternal separation.
Ladd CO; Huot RL; Thrivikraman KV; Nemeroff CB; Plotsky PM
Biol Psychiatry; 2004 Feb; 55(4):367-75. PubMed ID: 14960289
[TBL] [Abstract][Full Text] [Related]
11. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.
Butterweck V; Winterhoff H; Herkenham M
Mol Psychiatry; 2001 Sep; 6(5):547-64. PubMed ID: 11526469
[TBL] [Abstract][Full Text] [Related]
12. Central type 2 corticotropin-releasing hormone receptor mediates hypothalamic-pituitary-adrenocortical axis activation in the rat.
Maruyama H; Makino S; Noguchi T; Nishioka T; Hashimoto K
Neuroendocrinology; 2007; 86(1):1-16. PubMed ID: 17551262
[TBL] [Abstract][Full Text] [Related]
13. Blockade of the V(1b) receptor reduces ACTH, but not corticosterone secretion induced by stress without affecting basal hypothalamic-pituitary-adrenal axis activity.
Spiga F; Harrison LR; Wood S; Knight DM; MacSweeney CP; Thomson F; Craighead M; Lightman SL
J Endocrinol; 2009 Mar; 200(3):273-83. PubMed ID: 19008333
[TBL] [Abstract][Full Text] [Related]
14. Gonadal steroid replacement reverses gonadectomy-induced changes in the corticosterone pulse profile and stress-induced hypothalamic-pituitary-adrenal axis activity of male and female rats.
Seale JV; Wood SA; Atkinson HC; Harbuz MS; Lightman SL
J Neuroendocrinol; 2004 Dec; 16(12):989-98. PubMed ID: 15667454
[TBL] [Abstract][Full Text] [Related]
15. Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity.
Ochedalski T; Subburaju S; Wynn PC; Aguilera G
J Neuroendocrinol; 2007 Mar; 19(3):189-97. PubMed ID: 17280592
[TBL] [Abstract][Full Text] [Related]
16. Imidazoline2 (I2) receptor- and alpha2-adrenoceptor-mediated modulation of hypothalamic-pituitary-adrenal axis activity in control and acute restraint stressed rats.
Finn DP; Hudson AL; Kinoshita H; Coventry TL; Jessop DS; Nutt DJ; Harbuz MS
J Psychopharmacol; 2004 Mar; 18(1):47-53. PubMed ID: 15107184
[TBL] [Abstract][Full Text] [Related]
17. Normal hypothalamo-pituitary-adrenal axis function in a rat model of peripheral neuropathic pain.
Bomholt SF; Mikkelsen JD; Blackburn-Munro G
Brain Res; 2005 May; 1044(2):216-26. PubMed ID: 15885220
[TBL] [Abstract][Full Text] [Related]
18. Rapid alteration of stress-induced hypothalamic-pituitary-adrenal hormone secretion in the rat: a comparison of glucocorticoids and cannabinoids.
Ginsberg AB; Pecoraro NC; Warne JP; Horneman HF; Dallman MF
Stress; 2010 May; 13(3):248-57. PubMed ID: 20392196
[TBL] [Abstract][Full Text] [Related]
19. Consequences of prenatal morphine exposure on the hypothalamo-pituitary-adrenal axis in the newborn rat: effect of maternal adrenalectomy.
Lesage J; Grino M; Bernet F; Dutriez-Casteloot I; Montel V; Dupouy JP
J Neuroendocrinol; 1998 May; 10(5):331-42. PubMed ID: 9663647
[TBL] [Abstract][Full Text] [Related]
20. I.c.v. administration of the nonsteroidal glucocorticoid receptor antagonist, CP-472555, prevents exacerbated hypoglycemia during repeated insulin administration.
Kale AY; Paranjape SA; Briski KP
Neuroscience; 2006 Jun; 140(2):555-65. PubMed ID: 16626867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
